Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 01, 2015 12:13 AM ET

Biotechnology

Company Overview of Argos Therapeutics, Inc.

Executive Profile

Mark T. Weedon MBA

Former President, Chief Executive Officer and Director, Argos Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Mr. Mark T. Weedon, MBA serves as a Principal of BWA Consulting, a business group. Mr. Weedon served as President and Chief Executive Officer of Argos Therapeutics, Inc. (Formerly MERIX Bioscience, Inc.). Mr. Weedon joined Argos Therapeutics, Inc., in January 2001. Mr. Weedon has over 25 years of experience in the pharmaceutical industry; most recently he was with Scriptgen (now Anadys) Pharmaceuticals as President and Chief Executive Officer. In the prior decade at ...

Corporate Headquarters

4233 Technology Drive
Durham, North Carolina 27704

United States

Phone: 919-287-6300
Fax: --

Board Members Memberships

Director

Education

BA
University of Toronto
MBA
The University Of Western Ontario
MBA
University of Western Ontario, Ivey School of Business

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$375.0K
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
--
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
$1.1M
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Argos Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.